ARVEE2022-10-012022-12-31 ARVEE2022-10-012022-12-31 ARVEE2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member ARVEE2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member ARVEE2022-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 000000 ARVEE NOTLISTED Arvee Laboratories (India) Limited Equity 2022-04-01 2023-03-31 2023-02-02 2023-01-23 INR Lakhs Third quarter 11:30:00 12:45:00 2023-02-02 2023-02-02 Not applicable Single segment Chemicals 2022-10-01 2022-12-31 Unaudited Standalone 162508000.00 692000.00 163200000.00 117097000.00 0.00 -5604000.00 15400000.00 939000.00 4855000.00 18205000.00 150892000.00 12308000.00 0.00 12308000.00 3097000.00 0.00 3097000.00 0.00 9211000.00 0.00 0.00 0.00 0.00 9211000.00 0.00 9211000.00 0.00 0.00 110200000.00 10 0.84 0.84 0.00 0.00 0.84 0.84 1. The aforesaid Financial Results for the quarter and Nine Month ended December 31, 2022 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors at its Meeting held on Thursday, February 2, 2023. The Statutory Auditors of the Company have carried out a Limited Review of the aforesaid results, 2. The aforesaid Financial Results for the quarter and Nine Month ended December 31, 2022 have been prepared in accordance with Companies (Indian Accounting Standard) Rule, 2015 as prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and in terms of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3. In line with Ind AS - 108 Operating Segments and basis of the review of operations being done by the Senior Management, the operations of the Company fall under the Chemicals business which is considered to be the only reportable segment by the management. 4. The figures for the quarter ended December 31, 2022 are the balancing figures between unaudited figures of the nine months ended December, 31 2022 and unaudited figures in respect of the half year ended September 30, 2022. 5 Earnings Per Share is not annualised for the quarter and Nine months ended on the periods mentioned in the above results. 6 The figures for the corresponding Previous period have been restated / regrouped wherever necessary, to make them comparable Single segment 2022-04-01 2022-12-31 Unaudited Standalone 571678000.00 1542000.00 573220000.00 292995000.00 72448000.00 8191000.00 44944000.00 3165000.00 16037000.00 80521000.00 518301000.00 54919000.00 0.00 54919000.00 13821000.00 0.00 13821000.00 0.00 41098000.00 0.00 0.00 0.00 0.00 41098000.00 0.00 41098000.00 0.00 0.00 110200000.00 10 3.73 3.73 0.00 0.00 3.73 3.73 OTHER EXPENSES 18205000.00 OTHER EXPENSES 80521000.00